IMMUNOLOGICAL STATUS MAY PREDICT CLINICAL OUTCOME IN BCG TREATED MELANOMA

被引：4

作者：

REYNOLDS, PM

GRIMSLEY, G

DAWKINS, RL

BYRNE, MJ

ZILKO, PJ

机构：

[1] QUEEN ELIZABETH 2 MED CTR,DEPT CLIN IMMUNOL,NEDLANDS,W AUSTRALIA,AUSTRALIA

[2] ROYAL PERTH HOSP,DEPT CLIN IMMUNOL,PERTH 6001,W AUSTRALIA,AUSTRALIA

来源：

AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE | 1980年 / 10卷 / 01期

关键词：

D O I：

10.1111/j.1445-5994.1980.tb03416.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：39 / 43

页数：5

共 25 条

[1] INCREASE IN E ACTIVE ROSETTE FORMING LYMPHOCYTES IN MELANOMA PATIENTS TREATED WITH BCG [J].

BERTOGLIO, J ;

GERLIER, D ;

BOURGOIN, A ;

GRONNEBERG, K ;

DORE, JF .

EUROPEAN JOURNAL OF CANCER, 1977, 13 (4-5) :321-323

[2] IMMUNOLOGICAL EFFECTS OF BCG IN MALIGNANT-MELANOMA - 2 MODES OF ADMINISTRATION COMPARED [J].

BLUMING, AZ ;

VOGEL, CL ;

ZIEGLER, JL ;

KAMYA, G ;

MODY, N .

ANNALS OF INTERNAL MEDICINE, 1972, 76 (03) :405-+

[3]

BOURGOIN JJ, 1975, BEHRING I MITT, V56, P263

[4] IMMUNOLOGICAL EFFECTS OF BCG IN PATIENTS WITH MALIGNANT-MELANOMA - SPECIFIC EVIDENCE FOR STIMULATION OF SECONDARY IMMUNE-RESPONSE [J].

CHESS, L ;

BOCK, GN ;

UNGARO, PC ;

BUCHHOLZ, DH ;

MARDINEY, MR .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1973, 51 (01) :57-65

[5] PROGNOSTIC CORRELATIONS IN MALIGNANT-MELANOMA [J].

CLAUDY, AL ;

VIAC, J ;

PELLETIER, N ;

FOUADWASSEF, N ;

ALARIO, A ;

THIVOLET, J .

EUROPEAN JOURNAL OF CANCER, 1975, 11 (11) :821-827

[6] SEPARATION OF CELLS INVOLVED IN PHYTOHAEMAGGLUTININ-INDUCED MITOGENESIS AND CYTOTOXICITY [J].

DAWKINS, RL ;

ZILKO, PJ .

NATURE, 1975, 254 (5496) :144-145

[7]

ENG CP, 1976, P AM ASSOC CANC RES, V17, P33

[8]

GRIMSLEY G, 1977, AUSTRALASIAN TISSUE, P76

[9]

GROSS NJ, 1976, CANCER, V37, P2183, DOI 10.1002/1097-0142(197605)37:5<2183::AID-CNCR2820370505>3.0.CO

[10]

2-L

← 1 2 3 →